(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PREZISTA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

PREZISTA

ST13

US500000078762650

Class

5

Filing

78762650

Registration

3236346

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

05/02/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

11/29/2005

Registration date

05/01/2007

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/27/2016

Last transaction

05/02/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

06/26/2006

First use in commerce

06/26/2006

Drawing code

4

Owner type

79

Owner location

RINGASKIDDY, CO. CORK, IE

Examiner

STEEL, ALYSSA PALADINO

Law office

L70

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
J. U. (pessoa física)
JANSSEN R&D IRELAND
T. P. (pessoa física)
Tibotec Pharmaceuticals Ltd.

Representatives

Cheryl L. Foytlin JOHNSON & JOHNSON

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Human pharmaceuticalsnamely anti-virals for treatment of HIV

Publications

History of USPTO decisions and trademark events.

33 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/01/2026

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/06/2019

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/27/2016

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/27/2016

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/27/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/27/2016

E89R

TEAS SECTION 8 & 9 RECEIVED

07/08/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/01/2016

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/21/2015

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/15/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/15/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/15/2013

E815

TEAS SECTION 8 & 15 RECEIVED

02/04/2013

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

05/16/2012

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

01/12/2011

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/09/2010

R.PR

REGISTERED-PRINCIPAL REGISTER

05/01/2007

PUBO

PUBLISHED FOR OPPOSITION

02/13/2007

NPUB

NOTICE OF PUBLICATION

01/24/2007

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

01/09/2007

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/09/2007

IUAA

USE AMENDMENT ACCEPTED

01/09/2007

ACEC

AMENDMENT FROM APPLICANT ENTERED

01/03/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/03/2007

AUPC

AMENDMENT TO USE PROCESSING COMPLETE

01/03/2007

ALIE

ASSIGNED TO LIE

01/03/2007

MAIL

PAPER RECEIVED

11/27/2006

IUAF

USE AMENDMENT FILED

11/16/2006

EAAU

TEAS AMENDMENT OF USE RECEIVED

11/16/2006

GNRT

NON-FINAL ACTION E-MAILED

06/02/2006

CNRT

NON-FINAL ACTION WRITTEN

06/02/2006

DOCK

ASSIGNED TO EXAMINER

05/31/2006

NWAP

NEW APPLICATION ENTERED

12/05/2005

Continuous trademark protection

Get notified about every new filing that threatens PREZISTA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.